Antidepressants and hypothalamic-pituitary-adrenocortical regulation

Endocrine Reviews

Volumn 17, Issue 2, 1996, Pages 187-205

  Holsboer, Florian ^a   Barden, Nicholas ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CORTICOTROPIN; CYPROHEPTADINE; DESIPRAMINE; HYDROCORTISONE; IPSAPIRONE; MOCLOBEMIDE; OXAPROTILINE; TIANEPTINE;

ANIMAL CELL; ANIMAL TISSUE; DEPRESSION; DRUG MECHANISM; GENETIC RISK; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0029926722     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv-17-2-187     Document Type: Review

References (237)

1. Nestler EJ, Duman RS 1995 Intracellular messenger pathways as mediators of neural plasticity. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp 695-704
2. Gibbons JL 1964 Cortisol secretion rate in depressive illness. Arch Gen Psychiatry 10:572-575
3. Barden N, Reul JMHM, Holsboer F 1995 Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 18:6-11
4. Dallman MF 1993 Stress update. Adaptation of the hypothalamic-pituitary-adrenal axis to chronic stress. Trends Endocrinol Metab 4:62-69
5. Swanson LW 1991 Biochemical switching in hypothalamic circuits mediating responses to stress. Prog Brain Res 87:181-200
6. de Kloet ER 1991 Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 12:95-164
7. Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW 1992 The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA 89:4192-4196
8. Antoni FA 1993 Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14:76-122
9. Antoni FA 1986 Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 7:351-378
10. Tuomisto J, Männistö P 1985 Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 37:249-332
11. Orth DN 1992 Corticotropin-releasing hormone in humans. Endocr Rev 13:164-191
12. Owens MJ, Nemeroff CB 1991 Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473
13. Plotsky PM 1987 Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 121:924-930
14. Valentino RJ, Foote SL, Aston-Jones G 1983 Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 270:363-367
15. Valentino RJ, Foote SL, Page ME 1993 The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann NY Acad Sci 697:171-187
16. Berridge CW, Dunn AJ 1989 Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF. J Neurosci 9:3513-3521
17. Al-Damluji S, Cunnah D, Grossman A, Perry L, Ross G, Coy D, Rees LH, Besser GM 1987 Effect of adrenaline on basal and ovine corticotropin-releasing factor-stimulated ACTH secretion in man. J Endocrinol 112:145-150
18. Di Sciullo A, Bluet-Pajot MT, Mounier F, Oliver C, Schmidt B, Kordon C 1990 Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation. Endocrinology 127:567-572
19. 1 agonists in rat. Neuroendocrinology 50:241-247
20. 2 agonist, (±)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain. J Pharmacol Exp Ther 256:787-794
21. Calogero AE, Kamilaris TC, Gomez T, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP 1989 The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. Endocrinology 125:2445-2453
22. Keller-Wood ME, Dallman MF 1984 Corticosteroid inhibition of ACTH secretion. Endocr Rev 5:1-24
23. Tai PKKT, Albers MW, Chang H, Faber LE, Schreiber SL 1992 Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. Science 256:1315-1318
24. Pratt WB, Jolly DJ, Pratt DV, Hollenberg SM, Giguere V, Cadepond FM, Schweitzer-Groyer G, Catelli MG, Evans RM, Baulieu EE 1988 A region in the steroid-binding domain determines formation of the non-DNA-binding, 9 S glucocorticoid receptor complex. J Biol Chem 263:267-272
25. Vamvakopoulos NC, Chrousos GP 1994 Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocr Rev 15:409-420
26. Schöbitz B, de Kloet ER, Holsboer F 1994 Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 44:397-432
27. Sapolsky RM, Armanini MP, Sutton SW, Plotsky PM 1989 Elevation of hypophysial portal concentrations of adrenocorticotropin secretagogues after fornix transection. Endocrinology 125:2881-2887
28. Lamberts SWJ, Koper JW, de Jong FH 1991 The endocrine effects of long-term treatment with mifepristone (RU 486). J Clin Endocrinol Metab 73:187-191
29. Dodt C, Kern W, Fehm HL, Born J 1993 Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinology 58:570-574
30. Bradbury MJ, Strack AM, Dallman MF 1993 Lesions of the hippocampal efferent pathway (fimbria-fornix) do not alter sensitivity of adrenocorticotropin to feedback inhibition by corticosterone in rats. Neuroendocrinology 58:396-407
31. Beato M 1989 Gene regulation by steroid hormones. Cell 56:335-344
32. O'Malley B 1990 The steroid receptor superfamily: more excitement predicted for the future. Mol Endocrinol 4:363-369
33. Tsai MJ, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
34. Trapp T, Rupprecht R, Castrén M, Reul JMHM, Holsboer F 1994 Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the central nervous system. Neuron 13:1-6
35. Rupprecht R, Arriza JL, Spengler D, Reul JMHM, Evans RM, Holsboer F, Damm K 1993 Trans-activation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol Endocrinol 7:597-603
36. Funder JW 1994 Corticosteroid receptors and the central nervous system. J Steroid Biochem Mol Biol 49:381-384
37. Funder JW 1994 The tale of the guinea pig. Front Neuroendocrinol 15:384-389
38. Van Steensel B 1995 Steroid Receptors and Nuclear Structure. PhD Thesis of the University of Amsterdam, The Netherlands
39. Van Eekelen JAM, Jiang W, de Kloet ER, Bohn MC 1988 Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J Neurosci 21:88-94
40. Herman JP, Schäfer MKH, Young EA, Thompson R, Douglass J, Akil H, Watson SJ 1989 Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci 9:3072-3082
41. Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett ALN 1987 Neuroendocrine aspects of primary endogenous depression. Arch Gen Psychiatry 44:328-336
42. Carroll BJ, Curtis GC, Davies BM, Mendels J, Sugerman AA 1976 Urinary free cortisol excretion in depression. Psychol Med 6:43-50
43. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W 1984 Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342-1344
44. Carroll BJ 1982 The dexamethasone suppression test for melancholia. Br J Psychiatry 140:292-304
45. Holsboer F, Philipp M, Steiger A, Gerken A 1986 Multisteroid analysis after DST in depressed patients - A controlled study. J Affective Disord 10:241-249
46. Ribero SCM, Tandon R, Grunhaus L, Greden JF 1993 The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 150:1618-1629
47. Vale W, Spiess J, Rivier C, Rivier J 1981 Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213:1394-1397
48. Spiess J, Rivier J, Rivier C, Vale W 1981 Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci USA 78:6517-6521
49. Shibahara S, Morimoto Y, Furutani Y, Notake M, Takahashi H, Shimizu S, Horikawa S, Numa S 1983 Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J 2:775-779
50. Holsboer F, Gerken A, von Bardeleben U, Grimm W, Beyer H, Müller OA, Stalla GK 1986 Human corticotropin-releasing hormone in depression. Biol Psychiatry 21:601-611
51. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, Avgerinos P, Paul S, Oldfield EH, Cutler GB, Chrousos GP 1986 Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med 314:1329-1335
52. von Bardeleben U, Stalla GK, Müller OA, Holsboer F 1988 Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment. Biol Psychiatry 24:782-786
53. Lisansky J, Peake GT, Strassman RJ, Quails C, Meikle AW, Risch SC, Fava GA, Zownir-Brazis M, Hochla P, Britton D 1989 Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pretreated with metyrapone. Arch Gen Psychiatry 46:641-649
54. Rupprecht R, Lesch KP, Müller U, Beck G, Beckmann H, Schulte HM 1989 Blunted adrenocorticotropin but normal β-endorphin release after depression. J Clin Endocrinol Metab 69:600-603
55. Holsboer F, Gerken A, Stalla GK, Müller OA 1987 Blunted aldosterone and ACTH release after human CRH administration in depressed patients. Am J Psychiatry 144:229-231
56. Nemeroff CB, Krishnan KRR, Reed D, Leder R, Beam C, Dunnick R 1992 Adrenal gland enlargement in major depression. Arch Gen Psychiatry 49:384-387
57. Rubin RT, Phillips JJ, Sadow TF, McCracken JT 1995 Adrenal gland volume in major depression. Arch Gen Psychiatry 52:213-218
58. Dallman MF 1985 Control of adrenocortical growth in vivo. Endocr Res 10:213-242
59. Edwards AV, Jones CT 1987 The effect of splanchnic nerve stimulation on adrenocortical activity in conscious calves. J Physiol 382:385-396
60. Engeland WC, Gann DS 1989 Splanchnic nerve stimulation modulates steroid secretion in hypophysectomised dogs. Neuroendocrinology 50:124-131
61. Bruhn TO, Engeland WC, Anthony EL, Gann DS, Jackson IM 1987 Corticotropin releasing factor in the dog adrenal medulla is secreted in response to hemorrhage. Endocrinology 120:25-33
62. Edwards AV, Jones CT 1988 Secretion of corticotropin releasing factor from the adrenal during splanchnic nerve stimulation in conscious calves. J Physiol 400:89-100
63. Vinson GP, Hinson JP, Tóth IE 1994 The neuroendocrinology of the adrenal cortex. J Neuroendocrinol 6:235-246
64. Andreis PG, Neri G, Nussdorfer GG 1991 Corticotropin-releasing hormone (CRH) directly stimulates corticosterone secretion by the rat adrenal gland. Endocrinology 128:1198-1200
65. van Oers JWAM, Hinson JP, Binnekade R, Tilders FJH 1992 Physiological role of corticotropin releasing factor in the control of ACTH mediated corticosterone release from the rat adrenal gland. Endocrinology 130:282-288
66. Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK 1987 Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression - Implications for pathophysiology of DST nonsuppression. Biol Psychiatry 22:228-234
67. von Bardeleben U, Holsboer F 1989 Cortisol response to a combined dexamethasone-human corticotropin-releasing hormone (CRH) challenge in patients with depression. J Neuroendocrinol 1:485-488
68. von Bardeleben U, Holsboer F 1991 Effect of age upon the Cortisol response to human CRH in depressed patients pretreated with dexamethasone. Biol Psychiatry 29:1042-1050
69. Holsboer-Trachsler E, Hemmeter U, Stohler R, Hatzinger M, Gerhard U, Hobi V 1991 The dexamethasone-hCRH stimulation test and cognitive performance during antidepressive treatment with trimipramine. Eur Neuropsychopharmacol 1:338-340
70. Holsboer-Trachsler E, Hemmeter U, Hatzinger M, Seifritz E, Gerhard U, Hobi V 1994 Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment - Neurobiological and psychometric assessment of course. J Psychiatr Res 28:381-399
71. Lammers CH, Garcia-Borreguero D, Schmider J, Gotthardt U, Dettling M, Holsboer F, Heuser IJ 1995 Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls II. Biol Psychiatry 38:803-807
72. Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ 1995 Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression and in normal controls I. Biol Psychiatry 38:797-802
73. Schreiber W, Lauer CJ, Krumrey K, Holsboer F, Krieg JC 1996 Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder. Neuropsychopharmacology, in press
74. Heuser IJE, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, Holsboer F 1996 Pituitary-adrenal system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and in normal controls. Am J Psychiatry 153: 93-99
75. Hermus ARM, Pieters GFF, Smals AGH, Benraad TJ, Kloppenborg PWC 1984 Plasma adrenocorticotropin, cortisol and aldosterone responses to corticotropin-releasing factor: modulatory effect of basal cortisol levels. J Clin Endocrinol Metab 58:187-191
76. Heuser I, Yassouridis A, Holsboer F 1994 The combined dexamethasone/CRH-test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 28:341-356
77. Krieg JC 1994 Laboratory tests in depression: is it worth the effort? J Psychiatr Res 28:337-339
78. Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. JAMA 269:2232-2238
79. Grasser A, Möller A, Backmund H, Yassouridis A, Holsboer F 1995 Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp Clin Endocrinol Diabetes 104:31-37
80. Heuser I, Wark HJ, Keul J, Holsboer F 1991 Hypothalamic-pituitary-adrenal axis function in elderly endurance athletes. J Clin Endocrinol Metab 73:485-488
81. Hatzinger M, Z'Brun A, Hemmeter U, Seifritz E, Baumann F, Holsboer-Trachsler E, Heuser IJ 1995 Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease. Neurobiol Aging 16:205-210
82. von Bardeleben U, Holsboer F, Stalla GK, Müller OA 1985 Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci 37:1613-1618
83. Levin N, Roberts IL 1991 Positive regulation of proopiomelanocortin gene expression in corticotropes and melanotropes. Front Neuroendocrinol 12:1-22
84. De Goeij DCE, Kvetnansky R, Whitnall MH, Jezova D, Berkenbosch F, Tilders FJH 1991 Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology 53:150-159
85. Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry JM, Kiss JZ 1993 Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 132:895-902
86. Whitnall MH, Smyth D, Gainer H 1987 Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats. Neuroendocrinology 45:420-424
87. De Goeij DCE, Jezova D, Tilders FJH 1992a Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res 577:165-168
88. De Goeij DCE, Dijkstra H, Tilders FJH 1992b Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status. Endocrinology 131:847-853
89. Raadsheer FC, Hoogendijk WJG, Stam FC, Tilders FJH, Swaab DF 1994 Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Clin Neuroendocrinol 60:436-444
90. Purba JS, Hoogendijk WJG, Hofman MA, Swaab DF 1996 Increased number of vasopressin and oxytocin expressing neurons in the paraventricular nucleus of the human hypothalamus in depression. Arch Gen Psychiatry 53:137-143
91. Sawchenko PE 1987 Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res 403:213-224
92. Keller-Wood ME, Dallman MF 1984 Corticosteroid inhibition of ACTH secretion. Endocr Rev 5:1-24
93. Young EA, Haskett RF, Murphy-Weinberg V, Watson S, Akil H 1991 Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry 48:693-699
94. Holsboer F, Lauer CJ, Schreiber W, Krieg JC 1995 Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for depression. Neuroendocrinology 62:340-347
95. Steiger A, von Bardeleben U, Herth T, Holsboer F 1989 Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affective Disord 16:189-195
96. Starkman MN, Schteingart DE, Schork MA 1981 Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosom Med 43:3-18
97. Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA, Pickar D 1990 Prednisone effects on neurochemistry and behavior. Arch Gen Psychiatry 47:963-968
98. Wolkowitz OM, Weingartner H, Rubinow DR, Jimerson D, Kling M, Berrettini W, Thompson K, Breier A, Doran A, Reus VI, Pickar D 1993 Steroid modulation of human memory: biochemical correlates. Biol Psychiatry 33:744-746
99. Newcomer JW, Craft S, Hershey T, Asking K, Bardgett ME 1994 Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 14:2047-2053
100. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NPV, Meaney MJ 1994 Basal Cortisol levels and cognitive deficits in human aging. J Neurosci 14:2893-2903
101. Murphy BEP 1991 Treatment of major depression with steroid suppressive drugs. J Steroid Biochem Mol Biol 39:239-244
102. O'Dwyer AM, Lightman SL, Marks MN, Checkley SA 1995 Treatment of major depression with metyrapone and hydrocortisone. J Affective Disord 33:123-128
103. Wiedemann K, Lauer C, Loycke A, Durst P, Machér JP, Holsboer F 1992 Antiglucocorticoid treatment disrupts endocrine cycle and nocturnal sleep pattern. Eur Arch Psychiatry Clin Neurosci 241: 372-375
104. Holsboer F, Spengler D, Heuser I 1992 The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res 93:385-417
105. Dunn AJ, Berridge CW 1990 Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 15:71-100
106. Owens MJ, Bissette G, Nemeroff CB 1989 Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 4:196-202
107. Butler PD, Weiss JM, Stout JC, Nemeroff CB 1990 Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10: 176-183
108. Swerdlow NR, Britton KT, Koob GF 1989 Potentiation of acoustic startle by corticotropin-releasing factor and by fear are both reversed by alpha-helical CRF (9-41). Neuropsychopharmacology 2:285-292
109. Kalin NH, Takahashi LK 1990 Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone system. Brain Res 509:80-84
110. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT 1991 CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology 103:227-232
111. Heinrichs SC, Pich EM, Miczek KA, Britton KT, Koob GF 1992 Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res 581: 190-197
112. Swiergiel AH, Takahashi LK, Kalin NH 1993 Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res 623: 229-234
113. Imaki T, Vale W 1993 Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus. Brain Res 623:223-228
114. Skutella T, Criswell H, Moy S, Probst JC, Breese GR, Jirikowski GF, Holsboer F 1994 Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat. Neuroreport 5:2181-2185
115. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW 1994 Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 14:2579-2584
116. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W 1992 Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130:3378-3386
117. Muglia L, Jacobson L, Dikkes P, Majzoub JA 1995 Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373:427-432
118. Chen R, Lewis KA, Perrin MH, Vale WW 1993 Expression cloning of a human corticotropin-releasing factor receptor. Proc Natl Acad Sci USA 90:8967-8971
119. Chang CP, Pearse II RV, O'Connell S, Rosenfeld MG 1993 Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11:1187-1195
120. Vita N, Laurent P, Lefort S, Chalon P, Lelias JM, Kaghad M, Le FG, Caput D, Ferrara P 1993 Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 335:1-5
121. Lovenberg TW, Liaw CW, Grigoriadis DE, Cleveneger W, Chalmers DT, De Souza EB, Oltersdorf T 1995 Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840
122. 1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 59:229-239
123. Skutella T, Behl C, Probst JC, Renner U, Nitsch R, Holsboer F 1995 Modulation of corticotropin releasing hormone receptor in cell culture with antisense. J Mol Med 73:B25
124. Fuchs E, Flügge G 1995 Modulation of binding sites for corticotropin-releasing hormone by chronic psychosocial stress. Psychoneuroendocrinology 20:33-51
125. Landgraf R, Gerstberger R, Montkowski A, ProbstJC, Wotjak CT, Holsboer F, Engelmann M 1995 V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J Neurosci 15:4250-4258
126. Robinson BG, Emanuel RL, Frim DM, Majzoub JA 1988 Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 85:5244-5248
127. Swanson LW, Simmons DM 1989 Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J Comp Neurol 285:413-435
128. Imaki T, Nahan JL, Rivier C, Sawchenko PE, Vale W 1991 Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J Neurosci 11:585-599
129. Thompson RL, Seasholtz AF, Herbert E 1987 Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression. Mol Endocrinol 1:363-370
130. Emanuel RL, Girard DM, Thull DL, Majzoub JA 1990 Second messengers involved in the regulation of corticotropin-releasing hormone mRNA and peptide in cultured rat fetal hypothalamic primary cultures. Endocrinology 126:3016-3021
131. Phi Van L, Spengler D, Holsboer F 1990 Glucocorticoid repression of cAMP-dependent hCRH gene promoter activity in a transfected mouse anterior pituitary cell line. Endocrinology 127:1412-1418
132. Spengler D, Rupprecht R, Phi Van L, Holsboer F 1992 Identification and characterization of a 3′,5′-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. Mol Endocrinol 6:1931-1941
133. Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma I, Evans RM 1990 Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 62:1217-1226
134. Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, Herrlich P 1990 Antirumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204
135. Rangarajan PN, Umesono K, Evans RM 1992 Modulation of glucocorticoid receptor function by protein kinase. Mol Endocrinol 6:1451-1457
136. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustofsson JA, Van der Saag PT 1995 Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9:401-412
137. Ray A, Prefontaine KE 1994 Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756
138. Fink G, Robinson ICAF, Tannahill LA 1988 Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood. J Physiol 401:329-345
139. Davis LG, Arentzen R, Reid JM, Manning RW, Wolf son B, Lawrence KL, Baldino Jr F 1986 Glucocorticoid sensitivity of vasopressin mRNA levels in the paraventricular nucleus of the rat. Proc Natl Acad Sci USA 83:1145-1149
140. Hauger RL, Millan MA, Catt KJ, Aguilera G 1987 Differential regulation of brain and pituitary corticotropin-releasing factor receptors by corticosterone. Endocrinology 120:1527-1533
141. Hauger RL, Aguilera G 1993 Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin. Endocrinology 133:1708-1714
142. 1a vasopressin receptors by glucocorticoids. Am J Physiol 263:E1054-E1062
143. Saito R, Ishiharada N, Ban Y, Honda K, Takano Y, Kamiya H 1994 Vasopressin Vl receptor in rat hippocampus is regulated by adrenocortical functions. Brain Res 646:170-174
144. Drouin J, Sun YL, Nemer M 1990 Regulatory elements of the pro-opiomelanocortin gene. Pituitary specificity and glucocorticoid repression. Trends Endocrinol Metab 1:219-224
145. Drouin J, Sun YL, Chamberland M, Gauthier Y, De Lean A, Nemer M, Schmidt TJ 1993 Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J 12:145-156
146. Mobley PL, Sulser F 1980 Adrenal corticoids regulate sensitivity of noradrenaline receptor-coupled adenylate cyclase in brain. Nature 286:608-609
147. Collins S, Caron MG, Lefkowitz RJ 1988 β2-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 263:9067-9070
148. Hadcock JR, Malbon CC 1988 Regulation of β2-adrenergic receptors by "permissive" hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc Natl Acad Sci USA 85:8415-8419
149. Harrelson AL, Rostene W, McEwen BS 1987 Adrenocortical steroids modify neurotransmitter-stimulated cyclic AMP accumulation in the hippocampus and limbic brain of the rat. J Neurochem 48:1648-1655
150. 2 receptor binding and 5-HT transporter mRNA expression in rat brain. Brain Res 648: 157-161
151. 1A receptor mRNA expression. J Neurosci 13:914-923
152. 1A receptor gene expression by dexamethasone. Neuropsychopharmacology 10:215-222
153. 1 pyramidal neurons in vitro. Proc Natl Acad Sci USA 87:4495-4498
154. Joels M, Hesen W, de Kloet ER 1991 Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA, neurons. J Neurosci 11:2288-2294
155. Joëls M, de Kloet ER 1992 Control of neuronal excitability by corticosteroid hormones. Trends Neurosci 15:25-30
156. Azmitia EC, Liao B, Chen Y 1993 Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain. J Neurosci 13:5041-5055
157. Munck A, Guyre PM, Holbrook NJ 1984 Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5:25-44
158. Sapolsky RM, Krey LC, McEwen BS 1986 The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7:284-301
159. Stein-Behrens BA, Elliott EM, Miller CA, Schilling JW, Newcombe R, Sapolsky RM 1992 Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus. J Neurochem 58:1730-1735
160. 3H]D-aspartate overflow in hippocampal cultures during cyanide-induced ischemia. Brain Res 654:8-14
161. Lawrence MS, Sapolsky RM 1994 Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons. Brain Res 646:303-306
162. Saito N, Guitart X, Hayward M, Tallman JF, Duman RS, Nestler EJ 1989 Corticosterone differentially regulates the expression of G(s-alpha) and G(i-alpha) messenger RNA and protein in rat cerebral cortex. Proc Natl Acad Sci USA 86:3906-3910
163. Lesch KP, Lerer B 1991 The 5-HT receptor-G-protein-effector system complex in depression. I. Effect of glucocorticoids. J Neural Transm 84:3-18
164. oα subunits. Eur J Pharmacol 207:361-364
165. Manji HK 1992 G proteins: implications for psychiatry. Am J Psychiatry 149:746-760
166. Otten U, Baumann JB, Girard J 1979 Stimulation of the pituitary-adrenocortical axis by nerve growth factor. Nature 282:412-414
167. Taglialatela G, Angelucci L, Scaccianoce S, Foreman PJ, Perez-Polo JR 1991 Nerve growth factor modulates the activation of the hypothalamo-pituitary-adrenocortical axis during the stress response. Endocrinology 129:2212-2218
168. Scaccianoce S, Cigliana G, Nicolai R, Muscolo LA, Porcu A, Navarra D, Perez-Polo JR, Angelucci L 1993 Hypothalamic involvement in the activation of the pituitary-adrenocortical axis by nerve growth factor. Neuroendocrinology 58:202-209
169. Lindholm D, Castrén E, Hengerer B, Zafa F, Berninger B, Thoenen H 1992 Differential regulation of nerve growth factor (NGF) synthesis in neurons and astrocytes by glucocorticoid hormones. Eur J Neurosci 4:404-410
170. Kononen J, Soinila S, Persson H, Honkaniemi J, Hökfelt T, Pelto-Huikko M 1995 Neurotrophins and their receptors in the rat pituitary gland: regulation of BDNF and trkB mRNA levels by adrenal hormones. Mol Brain Res 27:347-354
171. Smith MA, Makino S, Kvetnansky R, Post RM 1995 Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15:1768-1777
172. Costa A, Trainer P, Besser M, Grossman A 1993 Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res 605:187-192
173. Rivier C, Shen GH 1994 In the rat, endogenous nitric oxide modulates the
174. Szabó C, Thiemermann C, Wu CC, Perretti M, Vane JR 1994 Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 91:271-275
175. Laakmann G, Schoen HW, Blaschke D, Wittmann M 1985 Dose-dependent growth hormone, prolactin and cortisol stimulation after i.v. administration of desimipramine in human subjects. Psychoneuroendocrinology 10:83-93
176. Asnis GM, Sanderson WC, van Praag HM 1992 Cortisol response to intramuscular desipramine in patients with major depression and normal control subjects: a replication study. Psychiatry Res 44:237-250
177. Laakmann GM, Wittmann M, Schoen HW, Zygan K, Weiss A, Meissner R, Müller OA, Stalla GK 1986 Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desipramine-induced pituitary hormone stimulation in humans. III. Hypothalamo-piruitary-adrenocortical axis. Psychoneuroendocrinology 10:83-93
178. Armario A, Garcia-Marquez C 1987 Tricyclic antidepressants activate the pituitary-adrenal axis in the rat. Tolerance to repeated drug administration. Eur J Pharmacol 140:239-244
179. Shimoda K, Yamada N, Ohi K, Tsujimoto T, Takahashi K, Takahashi S 1988 Chronic administration of tricyclic antidepressants suppresses hypothalamic-piruitary-adrenocortical activity in male rats. Psychoneuroendocrinology 13:431-440
180. Waldmeier PC, Baumann PA, Hauser K, Maitre L, Storni A 1982 Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer. Biochem Pharmacol 31:2169-2176
181. Steiger A, Gerken A, Benkert O, Holsboer F 1993 Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls. Eur Neuropsychopharmacol 3:117-126
182. Perez J, Tinelli D, Blanchi E, Brunello N, Racagni G 1991 cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NA reuptake blockers with antidepressant activity. Neuropsychopharmacology 4:57-64
183. Golden RN, Ekstrom D, Brown TM, Ruegg R, Evans DL, Haggerty Jr JJ, Garbutt JC, Pedersen CA, Mason GA, Browne J, Carson SW 1992 Neuroendocrine effects on intravenous clomipramine in depressed patients and healthy subjects. Am J Psychiatry 149:1168-1175
184. Daffner BC, Laakmann G, Baghai T, Haag C, Voderholzer U 1993 Influences of venaflaxine on growth hormone (GH) and other hormones in healthy subjects. Neuropsychopharmacology 9[Suppl 2]:100S-101S
185. Lewis D, Sherman BM 1984 Serotonergic stimulation of adrenocorticotropin secretion in man. J Clin Endocrinol Metab 58:458-462
186. Appel NM, Owens MJ, Culp S, Zaczek R, Contrera JF, Bissette G, Nemeroff CB, De Souza EB 1991 Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats. Endocrinology 128:3237-3246
187. Gibbs DM, Vale W 1983 Effects of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain Res 280:176-179
188. Walsh AES, Hockney RA, Campling G, Cowen PJ 1993 Neuroendocrine and temperature effects of nefazodone in healthy volunteers. Biol Psychiatry 33:115-119
189. Reist C, Albers L, Rosenzweig B, Chaay H, Helmeste D, Tang S 1994 Neuroendocrine responses to paroxetine. Neuropsychopharmacology 10[Suppl 3]:264S
190. 1A) receptor activation: effects of 5-HT receptor and β-adrenoceptor antagonists. J Clin Endocrinol Metab 70:670-674
191. 1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol Psychiatry 28:620-628
192. Holsboer F, Liebl R, Hofschuster E 1982 Repeated dexamethasone suppression test during depressive illness. Normalization of test result compared with clinical improvement. J Affective Disord 4:93-101
193. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z 1983 Dexamethasone suppression test in antidepressant treatment of melancholia. Arch Gen Psychiatry 40:493-500
194. Gerken A, Maier W, Holsboer F 1985 Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology. Psychoneuroendocrinology 10:261-271
195. Holsboer F, Steiger A, Maier W 1983 Four cases of reversion to abnormal dexamethasone suppression test response as indicator of clinical relapse: a preliminary report. Biol Psychiatry 18:911-916
196. De Bellis MD, Gold PW, Geracioti Jr TD, Listwak SJ, Kling MA 1993 Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry 150:656-657
197. Labrid C, Mocaer E, Kamoun A 1992 Neurochemical and pharmacological properties of tianeptine, a novel antidepressant. Br J Psychiatry 160:56-60
198. Delbende C, Contesse V, Mocaer E, Kamoun A, Vaudry H 1991 The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis. Eur J Pharmacol 202:391-396
199. Defrance R, Marey C, Kamoun A 1988 Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials. Clin Neuropharmacol 11[Suppl]:S74-S82
200. Reul JMHM, Stec I, Söder M, Holsboer F 1993 Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133:312-320
201. Reul JMHM, Labeur MS, Grigoriadis DE, De Souza EB, Holsboer F 1994 Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 60:509-519
202. Kitayama I, Janson AM, Cintra A, Fuxe K, Agnati LF, Ögren SO, Härfstrand A, Eneroth F, Gustafsson JA 1988 Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxyrryptamine nerve cell groups of the rostral ventromedial medulla. J Neural Transm 73:191-203
203. Seckl JR, Fink G 1992 Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 55:621-626
204. Brady LS, Whitfield Jr HJ, Fox RJ, Gold PW, Herkenham M 1991 Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in the rat brain. J Clin Invest 87:831-837
205. Nestler EJ, McMahon A, Sabban EL, Tallman JF, Duman RS 1990 Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus. Proc Natl Acad Sci USA 87:7522-7526
206. Roffler-Tarlov S, Schildkraut JJ, Draskoczy 1973 Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain. Biochem Pharmacol 22:2923-2926
207. Huang J, Maas JW, Hu GH 1979 The time course of noradrenergic pre- and postsynaptic activity during chronic desipramine treatment. Eur J Pharmacol 68:41-47
208. Melia KR, Nestler EJ, Duman RS 1992 Chronic imipramine treatment normalizes levels of tyrosine hydroxylase in the locus coeruleus of chronically stressed rats. Psychopharmacology 108:23-26
209. Brady LS, Gold PW, Herkenham M, Lynn AB, Whitfield Jr HJ 1992 The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res 572:117-125
210. Watanabe Y, Gould E, Cameron H, Daniels D, McEwen BS 1992 Stress and antidepressant effects on hippocampus. Eur J Pharmacol 222:157-162
211. Whitton P, Sarna G, O'Connell MT, Curzon G 1991 The effect of the novel antidepressant tianeptine on the concentration of 5-hydroxytryptamine in rat hippocampal dialysates in vivo. Neuropharmacology 30:1-4
212. Pepin MC, Beaulieu S, Barden N 1989 Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures. Mol Brain Res 6:77-83
213. Pepin MC, Barden N 1991 Decreased glucocorticoid receptor activity following glucocorticoid receptor antisense RNA gene fragment transfection. Mol Cell Biol 11:1647-1653
214. Pepin MC, Pothier F, Barden N 1992 Antidepressant drug action in a transgenic mouse model of endocrine changes seen in depression. Mol Pharmacol 42:991-995
215. Pepin MC, Govindan MV, Barden N 1992 Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol Pharmacol 41:1016-1022
216. Cole TJ, Blendy JA, Monaghan P, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schütz G 1995 Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9:1608-1621
217. Pepin MC, Pothier F, Barden N 1992 Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355:725-728
218. Wagner RW 1994 Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333-335
219. Walder RY, Walder JA 1988 Role of RNAse H in hybrid-arrested translation by antisense oligonucleotides. Proc Natl Acad Sci USA 85:5011-5015
220. Rosolen A, Kyle E, Chavany C, Bergan R, Kalman ET, Crouch R, Neckers L 1993 Effect of over-expression of bacterial ribonuclease H on the utility of antisense MYC oligodeoxynucleotides in the monocytic leukemia cell line U937. Biochimie 75:79-87
221. Richard D, Chapdelaine S, Deshaies Y, Pepin MC, Barden N 1993 Energy balance and lipid metabolism in transgenic mice bearing an antisense GCR gene construct. Am J Physiol 265:R146-R150
222. Stec I, Barden N, Reul JMHM, Holsboer F 1994 Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J Psychiatr Res 28:1-5
223. Peiffer A, Veilleux S, Barden N 1991 Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology 16:505-515
224. Montkowski A, Barden N, Wotjak C, Stec I, Ganster J, Meaney M, Engelmann M, Reul JMHM, Landgraf R, Holsboer F 1995 Long-term antidepressant treatment reduces behavioral deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol 7:841-845
225. Truss M, Beato M 1993 Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 14: 459-479
226. Castrén M, Trapp T, Berninger B, Castrén E, Holsboer F 1995 Transcriptional induction of rat mineralocorticoid receptor gene in neurons by corticosteroids. J Mol Endocrinol 14:285-293
227. Morris RGM 1984 Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60
228. Bluthe RM, Dantzer R 1990 Social recognition does not involve vasopressinergic neurotransmission in female rats. Brain Res 535: 301-304
229. Lister RG 1987 The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185
230. Peselow ED, Corwin J, Fieve RR, Rotrosen J, Cooper TB 1991 Disappearance of memory deficits in outpatient depressives responding to imipramine. J Affective Disord 21:173-183
231. Porsolt RD, Bertin A, Jalfre M 1978 "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51:291-294
232. West PA 1990 Neurobehavioral studies of forced swimming. The role of learning and memory in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 14:863-875
233. Allain H, Lieury A, Brunet-Bourgin F, Mirabaud C, Trebon P, Le Coz F, Gandon JM 1992 Antidepressants and cognition: comparative effects of moclobernide, viloxazine and maprotiline. Psychopharmacology 106:556-361
234. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T 1995 Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:8856-8860
235. Kühn R, Schwenk F, Aguet M, Rajewsky K 1995 Inducible gene targeting in mice. Science 269:1427-1429
236. Mclnnes IA, Freimer NB 1995 Mapping genes for psychiatric disorders and behavioral traits. Curr Opin Genet Dev 5:376-381
237. Post RM 1992 Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149:999-1010